Investorideas.com - House Approves Appropriations Amendment to Protect State-Legal Cannabis Markets
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Friday, July 31, 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 448 (CSE: $TER.C) (CSE: $CURA.C) (OTC: $HEMP)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 448 (CSE: $TER.C) (CSE: $CURA.C) (OTC: $HEMP)
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/073120-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/07311TER-CURA-HEMP.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
Open Book Extracts announced its expansion of operations and distribution channels into Asia, Israel and most recently, South Africa.
To serve a recently estimated $6.4 billion market opportunity for cannabis in South Africa, OBX was named a principal distribution partner of Peter Bodill Agencies LTD of South Africa. With more than 30 years in the agency/distribution business in South Africa, Peter Bodill Agencies represents manufacturers that specialize in supplying some of the world’s finest products, such as vitamin mixes, probiotics and industrial ingredients throughout the entire country. OBX joins global commercial distribution partner, Prinova Nagase Group, in a short list of principals vetted and approved by Peter Bodill Agencies for South African distribution.
“Quality, safety and reliability are essential in the burgeoning South Africa cannabis market,” stated Peter Bodill, director of Peter Bodill Agencies LTD. “The caliber of the team and products from Open Book Extracts has exceeded our expectations. We are excited to be able to provide its high-quality CBD products, innovative cannabinoid blends and pure rare cannabinoids to our clients.”
In addition to the South Africa distribution channel, OBX expanded its footprint into Asia, appointing Laurie Goldberg as OBX Asia’s chief executive officer. Goldberg, who founded and recently sold AmeriCraft Imports Limited, a Hong Kong-based craft beer importer and distributor, will lead expansion efforts into the Asia market.
“With the demand for CBD products in Asia growing rapidly, it is paramount for leading brands to have a reputable, quality supplier like Open Book Extracts,” stated Goldberg. “The fact that OBX is cGMP certified, able to deliver pharma-grade purity levels and is well versed in global market distribution ensures that we will meet the Asian market demand for high-quality, safe cannabinoid products.”
“We’re thrilled to expand our footprint to provide safe and efficacious cannabinoid products worldwide,” stated Dave Neundorfer, chief executive officer at OBX. “While we are glad to see countries roll out regulations to permit non-THC cannabinoids in food, beverages and personal care products, we’re also planning clinical trials for safety and efficacy to support dietary supplement and pharmaceutical registrations.”
The establishment of global distribution channels follows closely on the heels of Open Book Extracts’ recent acquisition of Chilmark Labs and its Israeli affiliate, Beetlebung Pharma Ltd., enabling the manufacturing of high-purity rare and minor cannabinoids at commercial scale, and further unlocking the therapeutic potential of cannabinoid-based products.
TerrAscend Corp. (CSE:TER) (OTCQX: TRSSF) today announced that it has officially opened its seventh retail dispensary location. The new 4,200 square foot Apothecarium dispensary, located at 2312 Telegraph Ave, Berkeley, CA is the company's fourth California dispensary, and TerrAscend's seventh dispensary nationwide.
The Apothecarium Berkeley is a full-service recreational and medical cannabis dispensary featuring a stylish, upscale design and a staff of highly trained cannabis consultants to assist guests. The store carries a wide variety of cannabis products, including edibles, flowers, vaping products, concentrates, capsules, tinctures, topicals, and ancillary products. The new location offers online ordering at apothecarium.com for pickup and delivery.
"We are excited to begin serving our East Bay customers from a beautiful new location on Telegraph Avenue," said Ryan Hudson, CEO, and co-founder of The Apothecarium. "At The Apothecarium, our focus is on education. We aim to provide one-on-one consultations that help our patients and customers find the right products for their needs. Whether they are looking for help in-person, by phone or via web chat, our cannabis consultants are here to help."
"For nearly a decade The Apothecarium has set the standard for dispensary design and customer service," said Jason Ackerman, CEO of TerrAscend. "The Apothecarium Berkeley is raising the bar again with a refined look and upgraded technology that brings the dispensary's famous consultations and cannabis education classes online. We're delighted to expand our footprint; Berkeley is our fourth California dispensary and our first in the East Bay."
The Apothecarium Berkeley is designed to be comfortable and easy to navigate for seniors, first-time dispensary visitors, and patients with serious medical conditions. The dispensary features The Apothecarium's typical mix of neo-Victorian furnishings, modern touches, and plenty of natural light. The store was designed by the same team behind The Apothecarium's three San Francisco dispensaries: architect Vincent Gonzaga and the interior design firm, Urban Chalet.
All Apothecarium dispensaries have implemented strict safety standards to protect guests and team members. Our California safety protocols include strict social distancing inside and outside the dispensaries, a mask requirement for everyone inside the dispensaries, no contact check-in procedures and ongoing sanitizing throughout the day.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced the launch of Curaleaf Sublingual Tablets in Florida. These cube-shaped, berry-flavored bites will provide the state's medical patients with a discreet, sugar-free yet fruity alternative form of medication.
Curaleaf's new Sublingual Tablets, which will be in 30-piece jars, contain 5mg of high-quality cannabis oil per piece, which allows patients to manage their treatment plan with confidence and ease. Each bite, which is made to be ingested orally or sublingually, is translucent in color and features a refreshing "Arctic Berry" flavor. The new product will be sold at all of the Company's 28 operating dispensaries in Florida with a phased roll-out between August 8th - August 20th. Limited quantities will be released to pre-existing loyalty patients beginning tomorrow, July 30th. For more information on the product roll-out cadence, please visit
https://curaleaf.com/blog/curaleaf-sublingual-tablets.
"The demand for alternative cannabis form functions in Florida has been mounting for years, and we are thrilled to offer our patients an exciting new product -- Sublingual Tablets," said Joe Lusardi, Chief Executive Officer at Curaleaf. "Our success is driven by listening to and meeting the needs of our patients, and we're incredibly proud to be first to market in Florida with this new option in cannabis medicine. By providing high-quality products in a variety of administration routes, we are better positioned to improve our patients' lives, which has been our mission since day one."
Earlier this summer, Curaleaf began selling "Shorties," a pre-roll flower product, in response to the requests of their Florida patients. As an additional offering to the classic 1g pre-roll, patients can now enjoy freshly harvested flower by way of these conveniently sized .4g pre-rolls.
Florida's continued growth in patient registration makes it one of the nation's fastest-growing medical cannabis markets in the country. Currently, there are over 377,000 medical patients enrolled in the Florida program - about 1.7% of the state's population - with approximately 5,000 new patients enrolling each week. To ensure the best possible service to the increasing number of medical patients, Curaleaf is in the process of expanding its Florida presence, adding to current grow capacity and planning to open at least five new dispensaries by Q4.
During the COVID-19 pandemic, cannabis businesses have been deemed an essential service in most states, including Florida. Curaleaf remains committed to serving patients and customers with the products they rely on while implementing heightened safety and hygienic measures in all its facilities.
Curaleaf's dispensary regular operating hours remain in effect, and free statewide delivery is always available for Florida medical patients. Throughout the year, discounts are offered to senior citizens, military veterans, pediatric patients, and recipients of government financial assistance. Please visit www.curaleaf.com/locations to find a dispensary near you.
Geocann announced that the company has commercialized the first oral dose application that overcomes the well-known bioavailability challenges of science-backed, key ingredients found in popular immunity support products. The multi-patented VESIsorb® delivery system provides the much-needed solution that turns the following poorly absorbed individual compounds into a synergistic, 4-in-1 formulation with dramatic improvements in absorption and bioavailability:
● 50 mg curcumin from turmeric root;
● 15 mg cannabidiol (CBD) from broad spectrum hemp extract;
● 7 mg beta-caryophyllene (BCP) that has received FDA GRAS status; and
● 200 IU vitamin D3.
“These ingredients have been strategically selected for their immunity support and anti-inflammatory properties, but are notorious for showing limited bioavailability due to their lipophilicity and extensive first-pass metabolism,” said Anthony Petraglia, M.D., Chief Medical Officer. “With a successful track record over the past fifteen years, VESIsorb® has consistently demonstrated its ability to mitigate these negative effects while significantly improving the pharmacokinetic performance of natural ingredients. To put it simply, bioavailability is the key to providing an immunity support product that delivers its desired health benefits.”
This formulation milestone comes on the heels of a study that was published in the peer-reviewed journal, Molecules, showcasing the numerous advantages of broad spectrum hemp extract formulated with VESIsorb® to that of the same broad spectrum hemp extract combined with medium chain triglycerides (MCT) oil. Key findings included that an important subgroup showed statistically significant improvements for all measured pharmacokinetic parameters, including a 712% increase in maximal plasma CBD concentration (Cmax), a 449% improvement in total CBD exposure over time [area under the curve (AUC)], and a 400% improvement in time to peak absorption (Tmax).
“Geocann has a strategic focus to deliver cannabinoid and terpene products with an unmatched body of supporting scientific evidence that address the most pressing health concerns,” said Sam Davidson, Chief Operating Officer. “The marketplace demand for natural immunity support products is unprecedented, and the relationship between a healthy immune system and a strong endocannabinoid system (ECS) is well-documented. More than ever, we are committed to pioneering these innovative solutions with our technical formulation expertise, rigorous product development protocol, and global distribution infrastructure.”
Geocann has the exclusive global rights to the patented VESIsorb® drug delivery technology for cannabinoids, terpenes, and flavonoid formulations. The company is strategically partnering with leading lifestyle brands that share a commitment to superior product safety, quality, and performance. The VESIsorb® drug delivery system has been successfully applied to a wide range of cannabis based product applications, including soft gel and hard shell capsules, functional foods (e.g. gummies) and beverages, powder systems, tinctures, sublingual sprays, and topically applied formulations.
Hemp, Inc. (OTC: HEMP) commended Congress for approving an amendment to the National Defense Authorization Act (NDAA) permitting military service members to use CBD and hemp-derived products.
The amendment supersedes months of confusion surrounding cannabidiol (CBD) policy earlier this year and addresses policies across military organizations following the legalization of hemp in the 2018 Farm Bill. The amendment also includes a measure allowing heads of military branches to issue reenlistment waivers to members of the armed forces who admit to using cannabis.
The approved measure is also celebrated by Hemp Inc.’s strategic hemp growing partner Veterans Village Kins Community in Arizona which is designed to grow hemp for CBD products that benefit veterans, generate revenues for the residents, and to support the holistic healing and learning center at the heart of the community.
“This is a step in the right direction for cannabis policy reform provisions and we’re very pleased that Congress has taken the initiative to allow military members to utilize the natural benefits of hemp to remedy the mental and physical effects of serving our country,” said Hemp, Inc. CEO Bruce Perlowin. “Working with our veteran partners at Veteran Village Kins Community in Arizona, Inc. we can see the good that CBD has on former military service members and this only illustrates the therapeutic and preventative effects it can have on active members as well.”
According to the Department of Defense Suicide Prevention (DoDSER) 2017 annual report, there were 1,397 non-fatal suicide attempts by active-duty service members. However, a 2015 study titled ‘Cannabidiol as a Potential Treatment for Anxiety Disorders’ showed CBD usage to be most effective in helping people deal with traumatic events within an hour of the experience, suggesting that using CBD while on active duty could probably decrease the development of PTSD and severe anxiety before it is too late.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Wednesday, July 29, 2020
Investorideas.com - California Cannabis Travel Association (CCTA) Aligns with Travel Industry Thought Leaders and Stakeholders, to Advance Cannabis Tourism
Investorideas.com - California Cannabis Travel Association (CCTA) Aligns with Travel Industry Thought Leaders and Stakeholders, to Advance Cannabis Tourism
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: $APHA.TO) (Nasdaq: $APHA) Announces Fourth Quarter and Fiscal Year 2020 Results
Investorideas.com - Cannabis Stock News: Aphria Inc. (TSX: $APHA.TO) (Nasdaq: $APHA) Announces Fourth Quarter and Fiscal Year 2020 Results
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Tuesday, July 28, 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 447 (TSX: $WEED.TO) (NYSE: $CGC) (NASDAQ: $GNLN) (CSE: $CRFT.C) (OTCQB: $GPFT)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 447 (TSX: $WEED.TO) (NYSE: $CGC) (NASDAQ: $GNLN) (CSE: $CRFT.C) (OTCQB: $GPFT)
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/072820-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/07281WEED-CGC-GNLN-CRFT-GPFT.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public company announcements.
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, announced the launch of its new U.S. e-commerce website: ShopCanopy.com.
ShopCanopy serves as the online home for Canopy Growth's growing portfolio of U.S. hemp-derived CBD product lines, and a one-stop shop for over 25 product SKUs from brands such as First & Free, This Works, and BioSteel. The site will continue to feature new brands from Canopy Growth, including the highly anticipated launch of Martha Stewart CBD.
"We're pleased to offer our customers a convenient, one-stop destination for exploring and purchasing Canopy Growth's products in the U.S.," said Sol Clahane, Vice President and General Manager – US Region, Canopy Growth. "As our exciting portfolio of hemp-based CBD products continues to grow and diversify, it's our ambition to offer competitively-priced, high quality products for each consumer need state and price point."
The intuitive, easy-to-navigate site allows consumers to search by brand or product category, such as softgels, oils, topicals or sport. ShopCanopy also features a robust educational component with more than 75 FAQs, blog posts and informative CBD educational material. The content provides consumers with an accessible, transparent, and trustworthy resource for science-backed information on CBD safety, dosing, benefits, product quality and more.
"We know consumers are looking for products they can trust in the nascent CBD industry," continued Clahane. As an industry leader, we see an opportunity to build brand loyalty by dealing directly with consumers through an e-commerce platform that brings Canopy Growth's entire product portfolio together in one place for the first time."
Canopy Growth is committed to selling only high-quality, tested and reliable products, and ensuring it makes no claims unless clinically validated. Every product sold on ShopCanopy will be accompanied by a Certificate of Analysis, which provides consumers with a complete list of third-party verified ingredients and testing to certify precise and accurate labeling of cannabinoid content, purity and safety. Canopy Growth only sells CBD products in states where it is permissible under state law in order to ensure compliance with state consumer protection mandates and following the most stringent state laws regarding sale of CBD. The Company is also abiding by existing FDA regulations for manufacturing, labeling and marketing dietary supplements.
For more information, or to purchase* Canopy Growth products, visit www.shopcanopy.com.
Greenlane Holdings, Inc. (NASDAQ: GNLN), one of the largest global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced the launch of VIBES™ Cubano Cones and a new VIBES apparel collection featuring six unique designs across 25 items. VIBES Fine Rolling Papers is a joint venture between Greenlane and Berner the extremely influential rapper, serial entrepreneur, and founder of Cookies. Cultivated and crafted in France, and then cut and kitted in the Dominican Republic, VIBES offers a curated assortment of premium cones, rolling paper and branded accessories with a mission to create the ultimate smoking experience for connoisseurs.
“We created and curated VIBES papers for the connoisseur with the goal of bringing true innovation to the industry. With the introduction of The Cubano, we have innovated upon the standard width and size of a traditional cone. We believe The Cubano uniquely compliments our generation, culture, and my cannabis brand: Cookies. I couldn’t be more excited to roll out The Cubano globally,” said Berner, CEO and Co-Founder of VIBES Rolling Papers.
The Cubano Cone is longer than a king size paper and significantly wider in diameter. Each cone is meticulously hand rolled with a structure capable of maintaining its shape when packed while the draft angle ensures it burns consistently all the way through. The Cubano is available in all three VIBES paper blends, Ultra Thin, Hemp, and Rice, and can hold up to 8 grams of dry material. As with all VIBES paper products, The Cubano uses all-natural acacia tree gum for a perfect seal. They are currently available in limited quantities through select authorized retailers, and vibespapers.com.
VIBES launched in 2019 and has gained a strong reputation for producing superior quality papers and connecting with consumers in an authentic way. VIBES apparel and accessories have allowed the company to make the jump from rolling papers to establishing itself as a genuine lifestyle brand.
In addition to its new Cubano Cones, VIBES will drop a new apparel collection on its website VibesPapers.com on Friday, July 31st.The collection consists of six new designs: GOAT, Cheetah, 3D, Joint Cloud, Queen, and Block spread across 25 items including shirts, hoodies, sweatshirts, fleece pants, and more. The featured graphics were crowd sourced through VIBES’ Instagram art contest held earlier this year in March. This new apparel collection expands on VIBES’ line of premium branded accessories. Visit VibesPapers.com after Friday, July 31st, to shop these products and more.
BC Craft Supply Co. Ltd. (CSE: CRFT) announced its first purchase of premium artisanal organic cannabis. BC Craft has purchased 29kg of BC Original Glue, which is pure organic, hand-trimmed, dried flower produced by Coast Mountain Cannabis. The flower will be packaged in beautiful 3.5 gram jars and in premium pre-rolls. BC Craft partnered with Indiva Limited under a master processing agreement (“MPA”) that was announced on May 13, 2020, to facilitate the processing and sales of premium cannabis procured through BC Craft’s vast network of artisanal craft cultivators. Under the MPA, Indiva brings state of the art processing, sales, and national distribution, which will allow micro and small scale cultivators access to the national recreational market and greater visibility for their brand and quality craft product.
BC Craft offers preferential payment terms for flower, with a 50% deposit and 50% payment within 30 days, thus allowing the Company to partner with premium small scale craft cultivators nationwide. BC Craft’s CEO, Matthew Watters stated, “Many of our suppliers have faced significant challenges when entering the regulated market. We chose these terms because while it is reasonable and advantageous for the Company, it also helps the cultivator. Most small batch cultivators are family run businesses and at BC Craft we believe that they deserve to be paid on time and at a fair price.”
CMC is a licensed boutique indoor cultivation facility located in Pemberton, B.C. nestled in the heart of the British Columbia’s Coast Mountain range. CMC’s team takes great pride in producing high quality organic cannabis which is reflected in their latest test results. CMC’s founders have deep roots in the Sea-to-Sky corridor; they came together with a shared vision and mission to build a leading edge facility, which respects the traditions of the industry and grows the best organic cannabis. At CMC, innovation and sustainability are at the heart of what they do. As champions of their community and the surrounding environment, they pride themselves on being a craft, ultra-premium producer, employing the best talent in the industry, and delivering a superior product and experience to their customers.
Matthew Watters, CEO further stated, “This is a pivotal moment in BC Craft’s vision and mandate to bring the highest quality artisanal cannabis into the legal market and serves to validate the Company's long term business model.”
Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that it has entered into an exclusive agreement with Grapefruit USA, Inc. (OTCQB:GPFT) to supply its Z-pod™ system as the technological underpinning of Grapefruit’s Hourglass™ time-release cannabinoid topical cream.
Zylö’s patented Z-pod™ system is formulated such that it enables a Patchless Patch™ product concept, whereby a topically applied cream provides ‘patch-like’ sustained release of a payload—such as cannabinoids or lidocaine—but without the hassles, inconvenience, and disposal issues of a patch. With certain payloads, the Z-pod™ delivery system also increases dermal penetration, improves stability, and/or enhances overall bioavailability.
Grapefruit, which holds licenses in California and Illinois to manufacture and distribute cannabis products (see www.grapefruitblvd.com), has exclusivity initially in these two states and has certain rights to expand the territory of exclusivity to other states and to Canada and Mexico. Canada has a well-established legalized cannabis marketplace, and it is anticipated that Mexico will legalize cannabis in the near future.
Grapefruit plans to introduce Hourglass™ on a limited basis to the California retail market by the end of the third quarter and to ramp up production and delivery of the product shortly thereafter. The architecture of the Hourglass™ delivery cream provides Grapefruit with the ability to formulate variations of its Hourglass™ product concept by loading the cream with unique blends of cannabinoids that its customers deem to be efficacious for a given application or desired result.
Scott Pancoast, Zylö’s CEO and founder, stated “We are enthusiastic about this partnership with Grapefruit and believe their Hourglass™ Topical Delivery Cream will be a game-changer in the recreational/medicinal full-spectrum cannabis market given the extraordinary advantages over traditional methods of consuming cannabis. We look forward to a long and expanding relationship with the Grapefruit team.”
Added Bradley J. Yourist, Grapefruit’s CEO, “We are excited and proud to have completed the developmental phase of Hourglass™, our breakthrough full-spectrum cannabinoid time-release topical delivery cream based on Zylö’s patented xerogel silica delivery system. We have developed an incredible collaborative working relationship with the Zylö team of scientists, which is evidenced by the scope of our agreement. We believe that Grapefruit’s Hourglass™ topical delivery cream is a truly disruptive, breakthrough technology, one that fundamentally changes the way individuals will use cannabinoids to obtain their unique benefits. Destructive and socially distasteful smoking of cannabis flowers and consumption of edibles that are metabolized unevenly are simply no longer necessary to enjoy both the medicinal and recreational benefits of cannabinoids. Furthermore, Grapefruit’s Hourglass™ Topical Delivery Cream offers cannabis users a heretofore unattainable level of discretion and anonymity. For example, fellow airline, train or ship passengers, concert goers, and movie or theatre attendees will not be able to detect any telltale odors normally associated with cannabis use.”
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)